Moe ST - Search Results

1

Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease.

Stowe GN, Silhár P, Hixon MS, Silvaggi NR, Allen KN, Moe ST, Jacobson AR, Barbieri JT, Janda KD. Stowe GN, et al. Among authors: moe st. Org Lett. 2010 Feb 19;12(4):756-9. doi: 10.1021/ol902820z. Org Lett. 2010. PMID: 20092262 Free PMC article.

2

Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs.

Moe ST, Thompson AB, Smith GM, Fredenburg RA, Stein RL, Jacobson AR. Moe ST, et al. Bioorg Med Chem. 2009 Apr 15;17(8):3072-9. doi: 10.1016/j.bmc.2009.03.013. Epub 2009 Mar 14. Bioorg Med Chem. 2009. PMID: 19329331 Free PMC article.

3

Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.

Thyagarajan B, Potian JG, Garcia CC, Hognason K, Capková K, Moe ST, Jacobson AR, Janda KD, McArdle JJ. Thyagarajan B, et al. Among authors: moe st. Neuropharmacology. 2010 Jun;58(8):1189-98. doi: 10.1016/j.neuropharm.2010.02.014. Epub 2010 Mar 6. Neuropharmacology. 2010. PMID: 20211192 Free PMC article.

4

Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1.

Jacobson AR, Moe ST, Allen PD, Fessenden JD. Jacobson AR, et al. Among authors: moe st. Mol Pharmacol. 2006 Jul;70(1):259-66. doi: 10.1124/mol.106.022491. Epub 2006 Apr 6. Mol Pharmacol. 2006. PMID: 16601083

5

Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.

Moe ST, Smith DL, DelMar EG, Shimizu SM, Van Wagenen BC, Balandrin MF, Chien YE, Raszkiewicz JL, Artman LD, White HS, Mueller AL. Moe ST, et al. Bioorg Med Chem Lett. 2000 Nov 6;10(21):2411-5. doi: 10.1016/s0960-894x(00)00470-4. Bioorg Med Chem Lett. 2000. PMID: 11078190

6

Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.

Portoghese PS, Sultana M, Moe ST, Takemori AE. Portoghese PS, et al. Among authors: moe st. J Med Chem. 1994 Mar 4;37(5):579-85. doi: 10.1021/jm00031a006. J Med Chem. 1994. PMID: 8126697

7

A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.

Portoghese PS, Moe ST, Takemori AE. Portoghese PS, et al. Among authors: moe st. J Med Chem. 1993 Aug 20;36(17):2572-4. doi: 10.1021/jm00069a017. J Med Chem. 1993. PMID: 8394935 No abstract available.

8

Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist.

Moe ST, Shimizu SM, Smith DL, Van Wagenen BC, DelMar EG, Balandrin MF, Chien Y, Raszkiewicz JL, Artman LD, Mueller AL, Lobkovsky E, Clardy J. Moe ST, et al. Bioorg Med Chem Lett. 1999 Jul 19;9(14):1915-20. doi: 10.1016/s0960-894x(99)00317-0. Bioorg Med Chem Lett. 1999. PMID: 10450953

9

Preparation and pharmacological evaluation of enantiomers of certain nonoxygenated aporphines: (+)- and (-)-aporphine and (+)- and (-)-10-methylaporphine.

Cannon JG, Raghupathi R, Moe ST, Johnson AK, Long JP. Cannon JG, et al. Among authors: moe st. J Med Chem. 1993 May 14;36(10):1316-8. doi: 10.1021/jm00062a002. J Med Chem. 1993. PMID: 8098770

10

Design, synthesis, and biological evaluation of spider toxin (argiotoxin-636) analogs as NMDA receptor antagonists.

Moe ST, Smith DL, Chien Y, Raszkiewicz JL, Artman LD, Mueller AL. Moe ST, et al. Pharm Res. 1998 Jan;15(1):31-8. doi: 10.1023/a:1011988317683. Pharm Res. 1998. PMID: 9487543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters